PROGRAM

Conference Program

PROGRAM
Invited International Speakers
§ Mark Guttman, Toronto, Canada
§ Carla Cordivari, National Hospital for Neurology and Neurosurgery, UK

Saturday, 16 March
Session 1 Sponsor - Pharmacia
09:00 - 09:10
Welcome and Opening Remarks
Andrew Hughes

9:10 - 9:50
Keynote Lecture
Chairs: Richard Peppard and Barry Snow
PET in PD: Serotonergic and Dopaminergic Systems
Mark Guttman (Toronto) (30')
Discussion 10'

Early PD
09:50 - 10:40
Management
Chairs: Peter Kempster and Richard Boyle
Levodopa remains the best first line treatment for PD
Mariese Healy (20')
Agonists are best practice for initial treatment of PD in the 21^st Century
Peter Silburn (20')
Combined Discussion (10')

10:40 Morning tea Sponsor - Faulding

Session 2 Sponsor - Novartis
Advanced PD
11:00 - 12:10
Management of motor fluctuations and dyskinesias
Chairs: Dudley O'Sullivan and Philip Thompson
Pharmacotherpay is a viable alternative to functional neurosurgery
in advanced PD
Michael Hayes (20')
When and why is DBS appropriate in advanced PD?
Robert Iansek (20')
Future directions for functional neurosurgery in PD
Raymond Cook (20')
Combined Discussion (10')

12:10 - 12:50
The burden of care of PD
Chairs: Malcolm Horne and Peter Silburn
The Burden of PD: a population based analysis
Mark Guttman (35')
Discussion (5')

12:50 Lunch Sponsor - Medtronic

Session 3 Sponsor - Ipsen
Complex Diagnostic and Management Problems I
Chairs - Robert Iansek and Ron Joffe

1:50 - 2:15
New insights into the neuropathology of dementia in PD
Glenda Halliday, Andrew Hughes (20')
Discussion (5')

2:15 - 2:40
REM and Sleep in PD
Rick Stell (20')
Discussion (5')

2:40 - 3:05
Management of Depression/Mood Disorders in PD
Malcolm Hopwood (20')
Discussion (5')

3:05 Afternoon tea Sponsor - Eli Lilly

3:25 - 4:00
Keynote Lecture
Chairs: Andrew Hughes and Bruce Day
Botulinum Toxin Therapy in uncommon and difficult dystonias
Carla Cordivari, (London) (30')
Discussion (5')

4:00 - 5:30
Video Session
Chairs: John Morris and Rick Stell

Sunday, 17 March
Session 4 Sponsor - Allergan
Complex Diagnostic and Management Problems II
Chairs: Robert Hjorth and Richard Lorentz

9:00 to 9:25
What determines quality of life in PD?
Andrew Churchyard (20')
Discussion (5')

9:25 - 9:50
DRD: an enlarging and evolving syndrome
Victor Fung (20')
Discussion (5')

9:50 - 10:05
Drooling and Botulinum toxin
John O'Sullivan (15')

10:05 to 10:20
Sweaty patients: how and when to do them
Richard Boyle (15')
Combined Discussion (5')

10:25 to 11:00
Clinical and electrophysiological guides in the assessment of psychogenic movement disorders
Carla Cordivari (30')
Discussion (5')

11:10 - 11:15
Closing Remarks
Andrew Hughes (15')